Glucose intolerance: Is it a risk factor for cardiovascular disease in children with chronic kidney disease?

Pediatric Nephrology

Volumn 27, Issue 4, 2012, Pages 627-635

  Canpolat, Nur ^a   Caliskan, Salim ^a   Sever, Lale ^a   Guzeltas, Alper ^a   Kantarci, Fatih ^a   Candan, Cengiz ^a   Civilibal, Mahmut ^a   Kasapcopur, Ozgur ^a   Arisoy, Nil ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Cardiovascular disease; Childhood; Chronic kidney disease; Glucose intolerance; Insulin resistance

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADOLESCENT; ARTERIAL WALL THICKNESS; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHILD; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HEART LEFT VENTRICLE HYPERTROPHY; HEMODIALYSIS PATIENT; HIGH RISK PATIENT; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; ORAL GLUCOSE TOLERANCE TEST; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; BLOOD; CHRONIC KIDNEY FAILURE; CROSS-SECTIONAL STUDY; GLUCOSE TOLERANCE TEST; PREVALENCE;

ADOLESCENT; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; INSULIN RESISTANCE; MALE; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84862271968     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-011-2034-3     Document Type: Article

References (50)

1. Groothoff JW, Gruppen MP, Offringa HJ, Lillien MR, Van De Kar NJ, Wolff ED, Davin JC, Heymans HS (2002) Mortality and causes of death of end-stage renal disease in children: A Dutch cohort study. Kidney Int 61:621-629 (Pubitemid 34102605)
2. Parekh RS, Carrol CE, Wolfe RA, Port FK (2002) Cardiovascular mortality in children and young adults with end-stage kidney disease. J Pediatr 141:191-197
3. Mitsnefes MM (2008) Cardiovascular complications of pediatric chronic kidney disease. Pediatr Nephrol 23:27-39 (Pubitemid 350245969)
4. Lillien MR, Groothoff JW (2009) Cardiovascular disease in children with CKD or ESRD. Nat Rev Nephrol 10:229-235
5. Shroff R, Quinlan C, Mitsnefes M (2011) Ureamic vasculopathy in children with chronic kidney disease: Prevention or damage limitation? Pediatr Nephrol 26:853-865
6. Wilson AC, Mitsnefes MM (2009) Cardiovascular disease in CKD in children: Update on risk factors, risk assessment, and management. Am J Kidney Dis 54:345-360
7. Ekundayo OJ, Muchimba M, Aban IB, Ritchie C, Campbell RC, Ahmed A (2009) Multimorbidity due to diabetes mellitus and chronic kidney disease and outcomes in chronic heart failure. Am J Cardiol 103:88-92
8. Menon V, Greene T, Pereira AA, Wang X, Beck GJ, Kusek JW, Collins AJ, Levey AS, Samak MJ (2005) Glycosylated hemoglobin and mortality in patients with nondiabetic chronic kidney disease. J Am Soc Nephrol 16:3411-3417 (Pubitemid 46179345)
9. Shinohara K, Shoji T, Emoto M, Tahara H, Koyama H, Ishimura E, Miki T, Tabata T, Nishizawa Y (2002) Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease. J Am Soc Nephrol 13:1894-1900 (Pubitemid 34700615)
10. Lai HL, Kartal J, Mitsnefes MM (2007) Hyperinsulinemia in pediatric patients with chronic kidney disease: The role of tumor necrosis factor-a. Pediatr Nephrol 22:1751-1756 (Pubitemid 47337431)
11. Lidbland YT, Axelsson J, Barany P, Celsi G, Lindholm B, Qureshi AR, Carrea A, Canepa A (2008) Hyperinsulinemia and insulin resistance, early cardiovascular risk factors in children with chronic kidney disease. Blood Purif 26:518-525
12. Mak RH (1998) Insulin, branched-chain amino acids, and growth failure in uremia. Pediatr Nephrol 12:637-642 (Pubitemid 28472918)
13. Shishido S, Sato H, Asanuma H, Shindo M, Hataya H, Ishikura K, Hamasaki Y, Goto M, Ikeda M, Honda M (2006) Unexpectedly high prevalence of pretransplant abnormal glucose tolerance in pediatric kidney transplant recipients. Pediatr Transplant 10:67-73
14. Mak RH, Haycock GB, Chantler C (1983) Glucose intolerance in children with chronic renal failure. Kidney Int 15[Suppl 1]:S22-S26
15. Greenspan LC, Gitelman SE, Leung MA, Glidden DV, Mathias RS (2002) Increased incidence in post-transplant diabetes mellitus in children: A case-control analysis. Pediatr Nephrol 17:1-5 (Pubitemid 41490196)
16. Prokai A, Fekete A, Kis E, Reusz GS, Sallay P, Korner A, Wagner L, Tulassay T, Szabo AJ (2008) Post-transplant diabetes mellitus in children following renal transplantation. Pediatr Transplant 12:643-649
17. Schwartz GJ, Gauthier B (1985) A simple estimate of glomerular filtration rate in adolescent boys. J Pediatr 106:522-526 (Pubitemid 15140671)
18. Neyzi O, Rzej F, Bundak R, Gunoz H, Darendeliler F, Bas F (2006) Growth references for Turkish children aged 6 to 18 years. Acta Pediatr 95:1635-1641 (Pubitemid 44863818)
19. Bundak R, Furman A, Gunoz H, Darendeliler F, Bas F, Neyzi O (2006) Body mass index references for Turkish children. Acta Pediatr 95:194-198 (Pubitemid 43189013)
20. American Diabetes Association (2010) Diagnosis and classification of diabetes mellitus. Diabetes Care 33[Suppl 1]:62-69
21. Matsumoto K, Miyake S, Yano M, Ueki Y, Yamaguchi Y, Akazawa S, Tominaga Y (1997) Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects. Diabetes Care 20:1562-1568 (Pubitemid 27415035)
22. D'Annunzio G, Vanelli M, Pistorio A, Minuto N, Bergamino L, Iafusco D, Lorini R, Diabetes Study Group of the Italian Society for Pediatric Endocrinology and Diabetes (ISPED) (2009) Insulin resistance and secretion indexes in healthy Italian children and adolescents: A multicenter study. Acta Biomed 80:21-28
23. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114:555-576
24. Sahn DJ, De Maria A, Kisslo J, Weyman A (1978) Recommendations regarding quantification in M-mode echocardiography: Results of a survey of echocardiographic measurements. Circulation 58:1072-1083 (Pubitemid 9091990)
25. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N (1986) Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. J Am Coll Cardiol 57:450-458 (Pubitemid 16119719)
26. De Simone G, Daniels SR, Devereux RB,Meyer RA, Roman MJ, de Diviitis O, AldermanMH(1992) Left ventricular mass and body size in normotensive children and adults: Assessment of allometric relations and impact of overweight. JAmColl Cardiol 20:1251-1260
27. De Simone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh JH (1995) Effect of growth on variability of left ventricular mass: Assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol 25:1056-1062
28. Jourdan C, Wühl E, Litwin M, Fahr K, Trelewicz J, Jobs K, Schenk JP, Grenda R, Mehls O, Tröger J, Schaefer F (2005) Normative values for intima-media thickness and distensibility of large arteries in healthy adolescents. J Hypertens 23:1707-1715 (Pubitemid 41233431)
29. Amendt P, Filler G (2000) Glucose metabolism in children with renal failure: Oral or intravenous glucose tolerance. Exp Clin Endocrinol Diabetes 108:253-258 (Pubitemid 30458595)
30. Mak RH (2008) Insulin and its role in chronic kidney disease. Pediatr Nephrol 23:355-362 (Pubitemid 351168112)
31. Mak RH, Ikizler AT, Kovesdy CP, Raj DS, Stenvinkel P, Kalantar-Zadeh K (2011) Wasting in chronic kidney disease. J Cachexia Sarcopenia Muscle 2:9-25
32. Siew ED, Pupim LB, Majchrzak KM, Shintani A, Flakol PJ, Ikizler TA (2007) Insulin resistance is associated with skeletal muscle protein breakdown in non-diabetic chronic hemodialysis patients. Kidney Int 71:146-152 (Pubitemid 46094688)
33. Alvestrand A, Mujagic M, Wajngot A (1989) Glucose intolerance in uremic patients: The relative contributions of impaired beta-cell function and insulin resistance. Clin Nephrol 31:175-183 (Pubitemid 19110635)
34. Buyan N, Bideci A, Ozkaya O, Ortac E, Bakkaloglu S, Gonen S, Peru H, Soylemezoglu O, Cinaz P (2006) Leptin and resistin levels and their relationships with glucose metabolism in children with chronic renal insufficiency and undergoing dialysis. Nephrology 11:192-196
35. Mak RH (1985) The influence of hyperparathyroidism on glucose metabolism in uremia. J Clin Endocrinol Metab 60:229-233 (Pubitemid 15129564)
36. Mak RH (1998) 1,25-Dihydroxyvitamin D3 corrects insulin and lipid abnormalities in uremia. Kidney Int 53:1353-1357 (Pubitemid 28316898)
37. Mak RH (1998) Effect of metabolic acidosis on insulin action and secretion in uremia. Kidney Int 54:603-607 (Pubitemid 28357424)
38. Mak RH (1996) Correction of anemia by erthyropoietin reverses insulin resistance and hyperinsulinemia in uremia. Am J Physiol 270:F839-F894
39. Barr EL, Zimmet PZ, Welborn TA, Jolley D, Magliano DJ, Dunstan DW, Cameron AJ, Dwyer T, Taylor HR, Tonkin AM, Wong TY, McNeil J, Shaw JE (2007) Risk of cardiovascular and all-cause mortality in individuals with diabetes-mellitus, impaired fasting glucose, and impaired glucose tolerance: The Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Circulation 116:151-157 (Pubitemid 47057520)
40. Brohall G, Oden A, Fogerberg B (2006) Carotid artery intima-media thickness in patients with Type 2 diabetes mellitus and impaired glucose intolerance: A systematic review. Diabet Med 23:609-616 (Pubitemid 43830060)
41. Hanefeld M, Temelkova-Kurktschiev T, Schaper F, Henkel E, Siegert G, Koehler C (1999) Impaired fasting glucose is not a risk factor for atherosclerosis. Diabet Med 16:212-218
42. Oh J, Wunsch W, Turzer M, Bahner M, Raggi P, Querfeld U, Mehls O, Schaefer F (2002) Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 106:100-105 (Pubitemid 34747448)
43. Litwin M, Wühl E, Jourdan C, Trelewicz J, Niemiska A, Fahr K, Jobs K, Grenda R, Wawer ZT, Rajszys P, Tröger J, Mehls O, Schaefer F (2005) Altered morphologic properties of large arteries in children with chronic renal failure and after renal transplantation. J Am Soc Nephrol 16:1494-1500 (Pubitemid 41716535)
44. Civilibal M, Caliskan S, Adaletli I, Oflaz H, Sever L, Candan C, Canpolat N, Kasapcopur O, Kuruoglu S, Arisoy N (2006) Coronary artery calcifications in children with end-stage renal disease. Pediatr Nephrol 21:1426-1433 (Pubitemid 44283475)
45. Drüeke T,Witko-Sarsat V, Massy Z, Descamps-Latcha B, Guerin AP, Marchais SJ, Gausson V, London GM(2002) Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease. Circulation 106:2212-2217 (Pubitemid 35222215)
46. Kalantar-Zadeh K, Rodriguez RA, Humphreys MH (2004) Association between serum ferritin and measures of inflammation, nutrition and iron in hemodialysis patients. Nephrol Dial Transplant 19:141-149 (Pubitemid 38072625)
47. Stenvinkel P, Heimburger O, Paultre F, Diczfalusy U, Wang T, Berglund L, Jogestrand T (1999) Strong association between malnutrition, inflammation and atherosclerosis in chronic renal failure. Kidney Int 55:648-658
48. Mitsnefes MM, Daniels SR, Schwartz SM, Meyer RA, Khoury P, Strife CF (2000) Severe left ventricular hypertrophy in pediatric dialysis: Prevalence and predictors. Pediatr Nephrol 14:898-902 (Pubitemid 30621296)
49. Mitsnefes M, Flynn J, Cohn S, Samuels J, Blydt-Hansen T, Saland J, Kimball T, Furth S, Warady B, for the CKiD study group (2010) Masked hypertension associates with left ventricular hypertrophy in children with CKD. J Am Soc Nephrol 21:137-144
50. Mitsnefes MM, Kimball TR, Kartal J, Witt SA, Glascock BJ, Khoury PR, Daniels SR (2005) Cardiac and vascular adaptation in pediatric patients with chronic kidney disease: Role of calcium-phosphorus metabolism. J Am Soc Nephrol 16:2796-2803